AF
PCRX icon

Advisornet Financial’s Pacira BioSciences PCRX Stock Holding History

Advisornet Financial’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-84
Closed -$1.26K – 2191
2024
Q3 		$1.26K Buy
84
+51
+155% +$872 ﹤0.01% 1879
2024
Q2 		$944 Hold
33
– – ﹤0.01% 1829
2024
Q1 		$964 Sell
33
-7
-18% -$215 ﹤0.01% 1771
2023
Q4 		$1.35K Hold
40
– – ﹤0.01% 1813
2023
Q3 		$1.23K Buy
40
+34
+567% +$1.23K ﹤0.01% 1757
2023
Q2 		$240 Sell
6
-1
-14% -$41 ﹤0.01% 2197
2023
Q1 		$286 Buy
+7
New +$278 ﹤0.01% 2195
2020
Q2 		– Sell
-850
Closed -$29K – 1887
2020
Q1 		$29K Buy
+850
New +$35.3K ﹤0.01% 962

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisornet Financial's PCRX Position: Q4 2024 in Review

Advisornet Financial sold out of Pacira BioSciences (PCRX) in Q4 2024, closing a stake of 84 shares — an estimated $1.26K sold.

Advisornet Financial first reported a position in PCRX in Q1 2020 and held it in 8 quarters. The position peaked at $29K in Q1 2020. 233 funds tracked by Wall St. Rank hold PCRX as of Q4 2024.

  • Advisornet Financial reported no remaining Pacira BioSciences position as of Q4 2024 after selling out during the quarter.
  • Advisornet Financial sold 84 Pacira BioSciences shares in Q4 2024, an estimated $1.26K.
  • Advisornet Financial first reported a position in Pacira BioSciences in Q1 2020 and held it in 8 quarters.
  • Advisornet Financial's Pacira BioSciences position peaked at $29K in Q1 2020.
  • 233 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2024.

Based on Advisornet Financial's 13F filing for Q4 2024, filed 13 Jan 2025.